10.1038/nature05414 103
Adiponectin in asthma: Implications for phenotyping
UK GLP-1 Surge- What Clinics Must Know: Recent data from Grand View Research shows that GLP-1 users in the UK have jumped from 2.3% in March 2024 to 4.1% today The UK weight-loss GLP-1 market is projected to reach US$715 million by 2030, growing at a 17.7% CAGR from 2025 to 2030
Key Benefits Enhance GLP-1 receptor activation and sustain its response with a combination of clinically studied prebiotics, probiotics, postbiotics, and fast-acting GLP-1 activators that work synergistically Control appetite by reducing cravings and stimulating satiety signals with hops extract, probiotic, and postbiotic* Promote digestive health and regularity with a prebiotic that promotes the growth of Akkermansia muciniphila for GLP-1 signaling Free from gluten, dairy, peanut, tree nut, fish, shellfish, soy, sesame, egg, active yeast, artificial flavors, colors, sweeteners, and unnecessary excipients
